Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 2

Research Article

The Efficacy and Safety of Traditional Chinese Medicine (Jiang Zhi Granule) for Nonalcoholic Fatty Liver: A Multicenter, Randomized, Placebo-Controlled Study

Table 2

(a) Primary outcome (L/S ratio) comparison between groups. (b) ANCOVA for mean change in L/S ratio from baseline to end of treatment.
(a)

Follow-upsFASPPS
JZGPlacebo JZGPlacebo

Baseline 0.0856 0.1366
Week 12
Week 12-baseline 0.0003 0.0015
Week 24
Week 24-baseline 0.0011 0.0003

values derived from paired -tests for baselines comparison between 2 groups and Wilcoxon signed-rank tests for difference value of L/S ratio from baseline to week 12 and week 24 of treatment.
(b)

FASPPS

Group38.85<0.000136.19<0.0001
Baseline13.690.000311.350.0009
Center7.250.007610.150.0017
Placebo group* (95% CI)0.07 (0.03, 0.11)0.07 (0.03, 0.12)
JZG group* (95% CI)0.24 (0.20, 0.28)0.25 (0.21, 0.30)
Mean change between
JZG and placebo group (95% CI)
−0.18 (−0.24, −0.12)−0.18 (−0.24, −0.12)

The values were for mean change in placebo group and mean change in JZG group of the complete treatment, respectively.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.